نتایج جستجو برای: apoptosis memantine

تعداد نتایج: 157062  

2017
Poupak Rahimzadeh Farnad Imani Nasim Nikoubakht Zahra Koleini Seyed Hamid Reza Faiz Azadeh Sayarifard

BACKGROUND Memantine is an N-methyl-D-Aspartate (NMDA) antagonist. By transferring acute postoperative pain, the NMDA channels may lead to active excess and neuropathic pain. Objectives: This study attempted to investigate the effect of preoperative use of single oral dose of memantine in controlling Dacryocystorhinostomy (DCR) postoperative pain. METHODS A double-blind clinical trial was con...

Journal: :The Journal of pharmacology and experimental therapeutics 2005
Yasco Aracava Edna F R Pereira Alfred Maelicke Edson X Albuquerque

The N-methyl-d-aspartate (NMDA) receptor antagonist memantine is an approved drug for treatment of Alzheimer's disease (AD). Other such treatments are cholinesterase inhibitors and nicotinic acetylcholine receptor (nAChR)-sensitizing agents such as galantamine. The present study was designed to test whether memantine exerts any effect on the cholinergic system, in particular the Ca(2+)-conducti...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 1992
H S Chen J W Pellegrini S K Aggarwal S Z Lei S Warach F E Jensen S A Lipton

Excessive activation of NMDA receptors is thought to mediate the calcium-dependent neurotoxicity associated with hypoxic-ischemic brain injury, trauma, epilepsy, and several neurodegenerative diseases. For this reason, various NMDA antagonists have been investigated for their therapeutic potential in these diseases, but heretofore none have proven to be both effective and safe. In the present s...

2013
Olivier Beauchet Cyrille P Launay Gazan Allali Gilles Watfa Karim Gallouj François R Herrmann Cédric Annweiler

BACKGROUND Anti-dementia drugs may improve gait performance. No comparison between acetylcholinesterase inhibitors (CEIs) and memantine-related changes in gait variability has been reported. The objectives of this study were to 1) quantify and compare the mean values and coefficients of variation (CoV) of stride time in demented patients with Alzheimer's disease and related disorders (ADRD) bef...

2010

Background: Glutamate deregulation may be involved in the neuropathology of schizophrenia, mainly through N-methyl-D-aspartate receptor (NMDAR) dysfunction. Memantine, which is approved for Alzheimer's disease, acts as a nonselective NMDAR antagonist. There have been some mixed results in some preliminary studies about adding memantine to antipsychotics in patients with schizophrenia in terms o...

Journal: :Investigative ophthalmology & visual science 1996
C K Vorwerk S A Lipton D Zurakowski B T Hyman B A Sabel E B Dreyer

PURPOSE It is well known that acute exposure to high concentrations of glutamate is toxic to central mammalian neurons. However, the effect of a chronic, minor elevation over endogenous glutamate levels has not been explored. The authors have suggested that such chronic exposure may play a role in glaucomatous neuronal loss. In the current study, they sought to explore whether a chronic, low-do...

Journal: :Turkish neurosurgery 2017
Mohammad-Bagher Ghayour Arash Abdolmaleki Morteza Behnam-Rassouli

AIM Following severe peripheral nerve injury (PNI), regeneration is often insufficient and functional recovery is incomplete. In this regard, glutamate N-methyl-D-aspartate (NMDA) receptor antagonist such as Memantine have been shown to have neuroprotective effects. We evaluated the effects of Memantine against sciatic nerve crush injury in male Wistar Rats. MATERIAL AND METHODS Memantine or ...

2012
Jingde Dong Mi Zhou Xiaoqiang Wu Mingyang Du Xiaoshan Wang

Memantine is a N-methyl-D-aspartate (NMDA) receptor antagonist approved for the treatment of moderate to severe Alzheimer's disease (AD). Environmental enrichment (EE) has shown significant beneficial effects on functional improvement in AD. In this study, we sought to determine whether combining these two distinct therapies would yield greater benefit than either drug used alone. We investigat...

2018
Maju Mathew Koola Ajay K. Parsaik

Cholinergic and glutamatergic systems, alpha-7 nicotinic acetylcholine receptor (α-7nAChR) and N-methyl-D-aspartate (NMDA) receptor are strongly implicated with cognitive impairments in Alzheimer's disease (AD). Donepezil, a frequently used drug in the treatment of AD, is only an acetylcholinesterase inhibitor (AChEI), whereas galantamine is an AChEI and a positive allosteric modulator of the α...

Journal: :The Lancet. Neurology 2015
Robert Howard Rupert McShane James Lindesay Craig Ritchie Ashley Baldwin Robert Barber Alistair Burns Tom Dening David Findlay Clive Holmes Robert Jones Roy Jones Ian McKeith Ajay Macharouthu John O'Brien Bart Sheehan Edmund Juszczak Cornelius Katona Robert Hills Martin Knapp Clive Ballard Richard G Brown Sube Banerjee Jessica Adams Tony Johnson Peter Bentham Patrick P J Phillips

BACKGROUND Findings from observational studies have suggested a delay in nursing home placement with dementia drug treatment, but findings from a previous randomised trial of patients with mild-to-moderate Alzheimer's disease showed no effect. We investigated the effects of continuation or discontinuation of donepezil and starting of memantine on subsequent nursing home placement in patients wi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید